×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| SHILPA MEDICARE LTD. | 1102.23 | 206.97 | 924.33 | 2.12 | 8,181 | 63.6 |
| MARKSANS PHARMA LTD. | 3217.44 | 480.56 | 3197.34 | 1.06 | 7901 | 22.6 |
| YATHARTH HOSPITAL & TRAUMA CAR | 1374.03 | 271.22 | 1301.44 | 2.81 | 7698 | 54.1 |
Shilpa Medicare Ltd., with Security Code 530549, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 66.5 | 83.7 | 74.6 | 64.0 | 87.5 | 96.1 | 129.7 | 125.4 | 126.2 | 92.4 |
| Expenses | 80.3 | 68.4 | 67.3 | 67.3 | 80.5 | 72.2 | 86.8 | 102.8 | 90.9 | 75.4 |
| Operating Profit | -13.8 | 15.3 | 7.3 | -3.3 | 7.0 | 23.9 | 42.9 | 22.6 | 35.3 | 17.0 |
| OPM % | -20.71% | 18.32% | 9.77% | -5.15% | 7.96% | 24.91% | 33.05% | 17.99% | 27.97% | 18.39% |
| Other Income | 5.4 | 14.4 | 22.5 | 22.2 | 19.5 | 31.0 | 21.0 | 16.3 | -30.2 | 12.6 |
| Interest | 6.6 | 6.8 | 5.2 | 2.6 | 2.7 | 1.9 | 1.2 | 1.4 | 2.1 | 2.2 |
| Depreciation | 12.0 | 12.3 | 12.7 | 12.4 | 12.3 | 12.3 | 12.0 | 12.2 | 12.3 | 12.6 |
| Profit before tax | -12.0 | 17.1 | 12.2 | 4.0 | 15.2 | 41.2 | 51.1 | 25.8 | 34.9 | 20.0 |
| Tax % | 7.2% | -26.6% | -45% | -31% | -14.8% | -30.3% | -39.8% | -36.4% | 0% | -40% |
| Net Profit | -28.9 | 7.9 | 6.6 | 2.7 | 9.7 | 28.3 | 30.5 | 16.1 | -5.2 | 20.7 |
| EPS in Rs | -3.33 | 0.91 | 0.76 | 0.31 | 1.12 | 2.94 | 3.12 | 1.65 | 0 | 2.12 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 262.5 | 263.6 | 260.2 | 313.0 | 286.5 | 291.7 | 292.5 | 343.8 | 319.3 | 330.8 |
| Expenses | 231.2 | 226.5 | 213.9 | 254.6 | 221.6 | 221.8 | 222.4 | 258.2 | 238.6 | 254.0 |
| Operating Profit | 31.3 | 37.0 | 46.3 | 58.4 | 64.9 | 69.9 | 70.1 | 85.6 | 80.7 | 76.8 |
| OPM % | 11.92% | 14.05% | 17.78% | 18.66% | 22.65% | 23.97% | 23.96% | 24.9% | 25.27% | 23.21% |
| Other Income | 2.7 | 2.2 | 1.9 | 1.8 | 2.2 | 8.6 | 9.4 | 5.0 | 1.1 | -20.5 |
| Interest | 17.9 | 17.7 | 18.2 | 23.2 | 26.2 | 24.2 | 23.7 | 25.6 | 11.7 | 14.5 |
| Depreciation | 24.1 | 25.7 | 26.7 | 27.8 | 26.7 | 26.6 | 27.1 | 28.3 | 28.8 | 28.8 |
| Profit before tax | -7.9 | -4.2 | 3.3 | 9.2 | 14.2 | 21.6 | 28.7 | 36.8 | 41.3 | 41.1 |
| Tax % | -12.1% | 126% | -42.7% | -68.6% | -62.1% | -11.5% | -45.4% | -50.7% | -23.8% | -5.4% |
| Net Profit | -6.6 | -8.0 | 1.2 | 1.6 | 4.7 | 24.5 | 14.1 | 17.9 | 31.8 | 14.5 |
| EPS in Rs | -0.76 | -0.93 | 0.14 | 0.19 | 0.53 | 2.82 | 1.46 | 1.83 | 3.25 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -5% |
| 5 Years: | -14% |
| 3 Years: | 6% |
| TTM: | 69% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -8% |
| 5 Years: | -22% |
| 3 Years: | -37% |
| TTM: | 258% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 14% |
| 3 Years: | 18% |
| 1 Year: | 46% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 9% |
| 3 Years: | 8% |
| TTM: | 11% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -9% |
| 5 Years: | -20% |
| 3 Years: | -33% |
| TTM: | 12021% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 14% |
| 3 Years: | 18% |
| 1 Year: | 46% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|